Slovak
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Epigenetics of Post-exertional Malaise in Patients With ME/CFS

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Odkaz sa uloží do schránky
PostavenieZatiaľ neprijímam
Sponzori
Vrije Universiteit Brussel

Kľúčové slová

Abstrakt

Exploring epigenetic mechanisms of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) is crucial to understand the mechanisms underlying its pathophysiology. Three potential candidates have been selected (BDNF, COMT, and HDAC genes). DNA methylation in the promoter regions of those genes will be explored.
The investigators designed a randomised controlled trial with cross-over design and will enrol 80 patients with ME/CFS and 25 age-, sex-, and BMI-matched healthy controls. Both groups will be randomised in 2 groups and receive either one session of aerobic exercise or a validated test designed to trigger mental stress and mental fatigue first. Then the two groups will cross over after a week wash period. The primary aim is to assess genetic and epigenetic mechanisms of BDNF, COMT and HDAC genes in response to exercise and the stress task.

Popis

The only way to improve the diagnosis and treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) is to better understand the mechanisms underlying its pathophysiology. Central nervous system dysfunctions play a major role in ME/CFS and help explaining patients' symptoms, such as general malaise occurring after physical activity (i.e. post-exertional malaise). Therefore, post-exertional malaise in relation to three major candidates involved in central nervous system functioning - brain-derived neurotrophic factor (BDNF), catechol-O-methyltransferase (COMT) and histone de-acetylases (HDAC) - will be explored.

BDNF is a protein involved in crucial functions such as nerve growth, memory and learning, and plays a role in neuronal sensitisation and pain. However, no study has explored the role of BDNF in ME/CFS. Our research group performed a preliminary study which focussed on BDNF in ME/CFS. In a previous study, the investigators assessed DNA methylation (an epigenetic mechanism that contribute to gene expression silencing), and protein expression in serum of the BDNF in patients with ME/CFS and healthy controls. Patients showed significantly less DNA methylation and significantly more BDNF protein. Given these exciting findings, further study is warranted.

COMT is an enzyme encoded by its homonymous gene. The enzyme degrades catecholamines like dopamine, epinephrine and norepinephrine. Catecholamines have been repeatedly associated with pain, stress, and depression. Lower COMT activity increases catecholamines level, causes hyperalgesia, and has been associated with depressive symptoms.

Similarly, research on histone acetylation shows that another group of enzymes (Histone de-acetylases, HDACs) are increased during neural sensitisation and pain. However, no research has been done on HDACs in patients with ME/CFS. Interestingly, aerobic exercise has been shown to increase BDNF release and decrease COMT and HDACs activity. Given the detrimental acute effects that exercise can have on patients with ME/CFS, investigators hypothesised that understanding the role of BDNF, COMT, and HDACs following exercise would help elucidating both mechanisms of post-exertional malaise and ME/CFS pathophysiology.

A randomised controlled trial with cross-over has been designed including 80 patients with ME/CFS and 25 age-, sex-, and BMI-matched healthy controls. Both groups will be randomised in 2 groups. One group will undergo one session of aerobic exercise, and the other group undergoes a validated test designed to trigger mental stress and mental fatigue. All participants will undergo clinical assessments, measurements of pain thresholds, and blood withdrawal before and after the exercise/mental stress exposure. The aims are to assess genetic and epigenetic mechanisms of BDNF, COMT and HDAC genes, as well as the expression of these factors in blood and serum in patients with ME/CFS.

Termíny

Naposledy overené: 04/30/2020
Prvý príspevok: 04/26/2020
Odhadovaná registrácia bola odoslaná: 05/04/2020
Prvý príspevok: 05/06/2020
Posledná aktualizácia bola odoslaná: 05/04/2020
Posledná aktualizácia bola zverejnená: 05/06/2020
Aktuálny dátum začatia štúdie: 09/30/2020
Odhadovaný dátum dokončenia primárneho okruhu: 09/29/2021
Odhadovaný dátum dokončenia štúdie: 09/29/2022

Stav alebo choroba

Fatigue Syndrome, Chronic

Intervencia / liečba

Behavioral: Exercise

Other: Mental Stress Test

Fáza

-

Skupiny zbraní

ArmIntervencia / liečba
Experimental: ME/CFS Exercise
Patients undergoing exercise first and the mental stress task after wash-out
Experimental: Patients Stress
Patients undergoing the mental stress task first and exercise after wash-out
Active Comparator: Healthy Exercise
Healthy controls undergoing exercise first and the mental stress task after wash-out
Active Comparator: Healthy Stress
Healthy controls undergoing the mental stress task first and exercise after wash-out

Kritériá oprávnenosti

Vek vhodný na štúdium 18 Years To 18 Years
Pohlavia vhodné na štúdiumFemale
Prijíma zdravých dobrovoľníkovÁno
Kritériá

Inclusion Criteria:

- diagnosis of ME/CFS established by a MD experienced in the field of internal medicine and ME/CFS - according to the published international criteria developed by the Centre for Disease Control and Prevention (CDC);

- age between 18 and 70 years old;

- body mass index (BMI) below 30 (no obesity).

Exclusion Criteria:

- presence of other neurological disorders (Parkinson's disease, Multiple Sclerosis, etc);

- presence of systemic disorders (lupus erythematosus, rheumatoid arthritis, etc.);

- presence or history of cardiac disorders (coronary heart disease, history of heart failure, etc);

- presence or history of cancer;

- presence or history of neuropathic pain (e.g. pain related to herpes zoster virus);

- pregnancy;

Výsledok

Primárne výstupné opatrenia

1. DNA methylation [Baseline through 1 week post intervention]

DNA methylation measured at several CpGs of the genes' promoter regions using pyrosequencing technology

Opatrenia sekundárnych výsledkov

1. Clinical Symptoms [Baseline (pre-intervention), immediately post-intervention, at 24-hours, at 1-week]

Symptoms reported by the patients using the DePaul Symptoms Questionniare

2. Pain sensitivity [Baseline (pre-intervention), immediately post-intervention, at 24-hours, at 1-week]

Sensitivity to mechanical stimuli using a digital algometer (FPXTM, Fisher, Wagner Instruments, Greenwich) as well as heat and cold stimuli using the TSA-II device (Medoc, CA, USA). The devices will be placed, in random order to prevent test order effects, at three different body sites: the skin web between thumb and index finger, trapezius muscle, and proximal third of tibialis anterior muscle, in order to test pain thresholds on non-specific locations both on the extremities and the trunk.

3. Serum BDNF [Baseline (pre-intervention), immediately post-intervention, at 24-hours, at 1-week]

BDNF protein expression in serum using Enzyme-Linked Immunosorbent Assay (ELISA) kit for human BDNF

4. Salivary Cortisol [Baseline (pre-intervention), immediately post-intervention, at 24-hours, at 1-week]

Cortisol levels will be measured in saliva and used as a measure of stress responses using LC/MS-MS method.

Ostatné výstupné opatrenia

1. General Health [Baseline]

General health will be measured using the Short Form-36 Health Survey (SF-36) questionnaire. The questionnaire returns a score from 0 to 100 where higher scores mean less disability.

2. Gene's polymorphisms [Baseline]

Genes' polymorphisms might mediate epigenetic changes. They will be assessed using pyrosequencing technology.

Pripojte sa k našej
facebookovej stránke

Najkompletnejšia databáza liečivých bylín podporovaná vedou

  • Pracuje v 55 jazykoch
  • Bylinné lieky podporené vedou
  • Rozpoznávanie bylín podľa obrázka
  • Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
  • Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
  • Vyhľadajte liečivé byliny podľa ich účinkov
  • Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi

Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume

Google Play badgeApp Store badge